Skip to main content
. 2012 Jun 4;33(9):1699–1706. doi: 10.1093/carcin/bgs192

Table II.

SNPs significantly associated with lung cancer risk in the discovery population

Gene SNP id Minor allele Casesa Controlsa Genetic model Adjusted OR b P value
ANKS1B rs10459194 g 310\295\50 439\406\114 Recessive 0.50 (0.32–0.77) 0.002
ANKS1B rs10745877 g 281\287\93 431\436\92 Recessive 1.60 (1.08–2.36) 0.019
ANKS1B rs11109966 a 249\341\71 415\424\120 Dominant 1.37 (1.06–1.78) 0.017
ANKS1B rs11110099 c 183\330\147 311\471\176 Additive 1.19 (0.99–1.43) 0.057
ANKS1B rs1403506 g 418\224\19 561\344\54 Additive 0.72 (0.58–0.89) 0.003
ANKS1B rs1523097 g 237\340\84 324\456\179 Recessive 0.55 (0.39–0.78) <0.001
ANKS1B rs1549102 c 195\341\125 274\456\229 Additive 0.80 (0.67–0.96) 0.015
ANKS1B rs201363 a 474\174\13 749\195\15 Dominant 1.50 (1.12–2.01) 0.006
ANKS1B rs4762543 a 244\335\82 333\449\177 Recessive 0.56 (0.39–0.79) 0.001
ANKS1B rs7135384 g 192\346\123 335\450\174 Dominant 1.49 (1.13–1.96) 0.005
ANKS1B rs7139028 a 236\347\78 339\445\175 Recessive 0.53 (0.37–0.76) <0.001
ANKS1B rs7301050 a 432\209\20 576\334\49 Additive 0.72 (0.57–0.89) 0.003
ANKS1B rs7959046 a 421\217\23 554\348\57 Additive 0.71 (0.57–0.88) 0.002
ANKS1B rs7963120 g 541\112\7 758\187\14 Dominant 0.63 (0.45–0.87) 0.005
ANKS1B rs869032 a 418\220\23 554\348\57 Additive 0.72 (0.58–0.89) 0.003
Bcl-2 rs12454650 g 323\294\44 526\357\76 Dominant 1.28 (1.00–1.65) 0.05
Bcl-2 rs12454712 g 230\339\91 392\444\121 Dominant 1.42 (1.09–1.85) 0.009
Bcl-2 rs1462129 a 175\335\151 288\472\199 Additive 1.30 (1.08–1.55) 0.005
Bcl-2 rs1982673 c 459\185\17 707\228\24 Dominant 1.28 (1.02–1.69) 0.034
Bcl-2 rs7243091 a 409\212\38 561\358\39 Dominant 0.78 (0.60–0.99) 0.04
Bcl-2 rs8098848 g 319\295\47 522\359\78 Dominant 1.28 (1.00–1.65) 0.05
Bcl-2 rs2255302 g 315\309\37 540\355\64 Dominant 1.69 (1.31–2.18) <0.001
Bcl-2 rs2551402 a 158\344\159 263\480\216 Additive 1.30 (1.08–1.55) 0.005
Bcl-2 rs2849371 a 315\309\37 534\360\65 Dominant 1.62 (1.26–2.09) <0.001
Bcl-2 rs2849372 g 314\310\37 534\360\65 Dominant 1.62 (1.26–2.09) <0.001
Bcl-2 rs2850767 c 263\317\81 425\427\107 Dominant 1.31 (1.01–1.69) 0.04
BID rs366542 g 165\332\164 280\458\221 Dominant 1.31 (1.00–1.75) 0.05
BMF rs11858141 g 233\332\96 285\492\182 Additive 0.78 (0.65–0.94) 0.008
BMF rs16970325 a 531\122\8 816\138\5 Dominant 1.35 (1.00–1.88) 0.05
BMF rs500804 a 293\300\68 515\366\78 Dominant 1.49 (1.15–1.92) 0.002
BMF rs537455 c 332\272\54 552\337\70 Dominant 1.49 (1.16–1.92) 0.002
CAPN2 rs12080565 a 602\57\2 850\103\5 Dominant 0.75 (0.49–0.97) 0.035
CAPN2 rs1222145 c 396\242\23 564\333\61 Recessive 0.51 (0.30–0.88) 0.014
CAPN2 rs16842040 a 630\31\0 891\65\3 Dominant 0.59 (0.34–0.99) 0.049
CASP3 rs2019978 c 408\228\25 624\300\35 Dominant 1.29 (1.02–1.67) 0.03
CASP8 rs3769823 a 312\295\54 507\378\74 Dominant 1.37 (1.06–1.76) 0.014
CASP9 rs4645989 g 311\277\72 490\384\83 Recessive 1.48 (1.02–2.24) 0.038
CASP9 rs6685648 g 312\277\72 489\388\82 Additive 1.17 (0.97–1.429) 0.102
CFLAR rs4487072 a 437\196\28 583\346\30 Dominant 0.79 (0.61–1.00) 0.049
CFLAR rs7583529 a 442\191\28 588\334\36 Dominant 0.81 (0.62–1.00) 0.049
CASP2 rs17164250 a 404\212\44 606\308\43 Recessive 2.13 (1.24–6.67) 0.006
CASP2 rs2272256 a 371\258\31 539\353\67 Recessive 0.62 (0.35–0.99) 0.044
DAXX rs2239839 a 346\269\45 470\389\100 Recessive 0.59 (0.37–0.93) 0.02
DAXX rs2282851 a 347\269\45 469\390\100 Recessive 0.58 (0.37–0.92) 0.02
FADD rs10898847 a 206\335\120 346\465\148 Dominant 1.30 (1.03–1.64) 0.03
FAS rs2147419 c 345\259\57 451\422\86 Dominant 0.79 (0.61–1.01) 0.06
FOXO1A rs17630266 a 600\58\2 902\55\2 Dominant 1.75 (1.09–2.80) 0.02
BAX rs1042265 a 535\117\9 813\140\6 Dominant 1.53 (1.10–2.12) 0.011
BAX rs2270937 a 274\315\72 445\419\95 Dominant 1.29 (1.00–1.67) 0.049
NCR3 rs2844480 a 406\224\31 632\284\43 Dominant 1.46 (1.12–1.90) 0.005
TNFRSF10A rs2230229 g 498\149\14 690\241\28 Dominant 0.67 (0.50–0.89) 0.007
TNFRSF10D rs3924519 g 365\252\44 474\409\76 Additive 0.81 (0.66–0.99) 0.04
TNFRSF1A rs2228576 a 293\310\58 401\437\121 Recessive 0.72 (0.49–1.01) 0.06
TNFRSF21 rs2236037 a 518\134\9 774\178\7 Dominant 1.35 (1.00–1.85) 0.049
TRAF2 rs2811761 g 375\245\39 613\309\36 Additive 1.29 (1.04–1.60) 0.02

aThe number of subjects of the WW (wild-type), WM (heterozygous) and MM (homozygous variant) genotypes: WW\WM\MM.

bAdjusted for age, gender, smoking status, pack year of smoking, asbestos exposure and lung cancer in first-degree relatives.